Key terms

About BCDA

BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest BCDA news

Mar 13 7:27am ET BioCardia, StemCardia enter biotherapeutic delivery partnership by TipRanks Mar 13 7:12am ET BioCardia Partners with StemCardia for Heart Therapy Trials by TipRanks Mar 12 7:30am ET BioCardia announces CMS approval of coverage of CardiAMP Phase III study by TipRanks Mar 06 11:12am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 04 8:05am ET BioCardia reports interim results from Phase III CardiAMP cell therapy trial by TipRanks Feb 14 4:39pm ET BioCardia files to sell 3.02M shares of common stock for holders by TipRanks Feb 10 4:15am ET BioCardia Inc Secures Funding Through Private Placement by TipRanks Feb 10 4:14am ET BioCardia Inc Conducts Unregistered Equity Securities Sale by TipRanks Feb 09 4:08am ET BioCardia Launches Pivotal CardiAMP HF II Trial by TipRanks Feb 08 7:11am ET BioCardia announces activation of CardiAMP heart failure II phase 3 study by TipRanks Jan 31 7:11am ET BioCardia announces two abstracts accepted at 2024 THT conference by TipRanks Jan 03 7:12am ET BioCardia issues letter to shareholders by TipRanks Dec 19 7:05am ET BioCardia doses first patient in CardiALLO Phase I/II trial of BCDA-03 by TipRanks

No recent news articles are available for BCDA

No recent press releases are available for BCDA

BCDA Financials

1-year income & revenue

Key terms

BCDA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

BCDA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments